MUTYH and acute kidney injury: However, our results showed that overexpression of type 2 MUTYH, but not type 1, in vivo ameliorated cisplatin‐induced AKI, although overexpression of both type 1 and type 2 MUTYH protected against cisplatin‐induced apoptosis and mitochondrial dysfunction in vitro.